NCT04938609 2026-04-09Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)Providence Health & ServicesPhase 2 Active not recruiting28 enrolled
NCT02474368 2025-07-10Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and NeckDana-Farber Cancer InstitutePhase 1 Active not recruiting21 enrolled